The quest for weight loss has become increasingly complex, as our biology drives us to eat more food when it’s available. The abundance of calorie-rich foods over the past 100 years has led to an evolutionary shift, where excess fat can become a threat to our health.
Fortunately, a new class of drugs called Glucagon-like peptide 1 receptor agonists (GLP-1R) agonists have been recognized as a breakthrough in weight loss treatment. These medications have been around for 20 years but are now being touted as effective long-term solutions.
Studies have shown that these drugs can lead to significant weight loss and improved energy levels, with some users reporting increased mobility. However, there’s also concern about the potential for muscle loss, which can be a critical issue in older adults.
Research suggests that losing weight without maintaining muscle mass can have severe consequences on quality of life. As we age, our bodies naturally lose muscle mass, and this process accelerates over 40-45 years old. The new weight loss medications may promote lean mass loss alongside fat loss, making it crucial for users to exercise regularly and consume sufficient protein to retain muscle.
While the benefits of these drugs are promising, caution is warranted, particularly in older adults. Further research is needed to understand the long-term effects of using GLP-1R agonists on muscle mass. For now, users should proceed with prudence and consult with healthcare professionals to ensure a balanced approach to weight loss and overall health.
Source: https://theconversation.com/preserving-muscle-with-glp-1-weight-loss-drugs-big-deal-or-nothing-to-worry-about-245833